Nitrosamine impurities – are you ready to fulfil your legal obligations as a MAH by March 26th, 2020?
12 February 2020
During the summer 2018, authorities become aware of the presence of some nitrosamines in API – (Valsartan – presence of N- nitrosodimethylamine (NDMA) - other sartans – presence of N-nitrosodiethylamine NDEA). Nitrosamines are chemical compounds classified as probable human carcinogens…
BlueReg continues to expand in the US opening its second North American office in Boston.
13 January 2020
Cambridge, Massachusetts, USA, December 13 2019, BlueReg, the consulting organization for life sciences companies, is announcing a development of its presence in North America by opening its second office in Boston in the United States. Located at the heart…
7 January 2020
Season's Greeting's from everyone at BlueReg ! We wish you a happy new year 2020 !
CPHI Worldwide in Frankfurt
24 October 2019
BlueReg Team will attend the CPHI Worldwide in Frankfurt, from November 5 to 7. Our experts would be there to discuss about your needs concerning Pharmaceutical Development, Regulatory Support, Project Management, CDMO Management and Scientific Writing. BlueReg, your partner for…